Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
HHSN268201600038C
IGF::OT::IGF THE DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA (COA) IN NEONATES.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NHLBI |
| NAICS | 541712 |
| PSC | AF11 — EDUCATION, TRAINING, EMPLOYMENT, & SOCIAL SVCS R&D SVCS; EDUCATION SVCS R&D; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $3.4M |
| Current contract value | $3.4M |
| Potential contract value / ceiling | $3.4M |
| Start date | Sep 26, 2016 |
| Current end date | Mar 22, 2022 |
| Potential end date | Mar 22, 2022 |
| Latest award activity | Feb 9, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 9, 2026 | P00005 | $0 | PHASE II- SBIR TOPIC 096 THE DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA (COA) IN NEONATES. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.